{
  "id": "58b67fae22d3005309000009",
  "type": "yesno",
  "question": "Does the TOP2B/TOP2A expression ratio affect the response to AML chemotherapy?",
  "ideal_answer": "High TOP2B/TOP2A expression ratio at diagnosis correlates with favourable outcome for standard chemotherapy in acute myeloid leukaemia Genes with distinct expression profiles such as TOP2B/TOP2A expression ratio at diagnosis can be employed for outcome prediction after the treatment with standard regimens in AML patients with M2 subtype.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/22627319"
  ],
  "snippets": [
    {
      "text": "High TOP2B/TOP2A expression ratio at diagnosis correlates with favourable outcome for standard chemotherapy in acute myeloid leukaemia",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22627319",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Genes with distinct expression profiles such as TOP2B/TOP2A expression ratio at diagnosis can be employed for outcome prediction after the treatment with standard regimens in AML patients with M2 subtype.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22627319",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Another interesting finding is that high ratios of TOP2B/RRM2 and TOP2B/TOP2 alpha (TOP2A) in a combined analysis were also shown to have a prognostic impact for longer survival with improved accuracy.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22627319",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Among the four markers, when adjusted for the influence of other clinical factors in multivariate analysis, the TOP2B/TOP2A ratio was significantly correlated with treatment outcomes; patients with high ratios trended toward longer disease-free survival (HR, 0.24; P=0.002) and overall survival (HR, 0.29; P=0.005)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22627319",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "High TOP2B/TOP2A expression ratio at diagnosis correlates with favourable outcome for standard chemotherapy in acute myeloid leukaemia.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22627319",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Among the four markers, when adjusted for the influence of other clinical factors in multivariate analysis, the TOP2B/TOP2A ratio was significantly correlated with treatment outcomes; patients with high ratios trended toward longer disease-free survival (HR, 0.24; P=0.002) and overall survival (HR, 0.29; P=0.005).Genes with distinct expression profiles such as TOP2B/TOP2A expression ratio at diagnosis can be employed for outcome prediction after the treatment with standard regimens in AML patients with M2 subtype",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22627319",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "CONCLUSION: Genes with distinct expression profiles such as TOP2B/TOP2A expression ratio at diagnosis can be employed for outcome prediction after the treatment with standard regimens in AML patients with M2 subtype.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22627319",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Genes with distinct expression profiles such as TOP2B/TOP2A expression ratio at diagnosis can be employed for outcome prediction after the treatment with standard regimens in AML patients with M2 subtype..",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22627319",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "High TOP2B/TOP2A expression ratio at diagnosis correlates with favourable outcome for standard chemotherapy in acute myeloid leukaemia.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22627319",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Among the four markers, when adjusted for the influence of other clinical factors in multivariate analysis, the TOP2B/TOP2A ratio was significantly correlated with treatment outcomes; patients with high ratios trended toward longer disease-free survival (HR, 0.24; P=0.002) and overall survival (HR, 0.29; P=0.005).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22627319",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Another interesting finding is that high ratios of TOP2B/RRM2 and TOP2B/TOP2 alpha (TOP2A) in a combined analysis were also shown to have a prognostic impact for longer survival with improved accuracy.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22627319",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}